192 related articles for article (PubMed ID: 11002235)
41. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?
Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
Arch Immunol Ther Exp (Warsz); 2001; 49(6):423-30. PubMed ID: 11814236
[TBL] [Abstract][Full Text] [Related]
42. Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with colorectal cancer.
Basoglu M; Yildirgan MI; Taysi S; Yilmaz I; Kiziltunc A; Balik AA; Celebi F; Atamanalp SS
J Surg Oncol; 2003 Jul; 83(3):180-4. PubMed ID: 12827689
[TBL] [Abstract][Full Text] [Related]
43. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
López-Guillermo A; Colomo L; Jiménez M; Bosch F; Villamor N; Arenillas L; Muntañola A; Montoto S; Giné E; Colomer D; Beà S; Campo E; Montserrat E
J Clin Oncol; 2005 Apr; 23(12):2797-804. PubMed ID: 15728226
[TBL] [Abstract][Full Text] [Related]
44. [Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction].
Bossowska A; Kiersnowska-Rogowska B; Bossowski A; Galar B; Sowiński P
Przegl Lek; 2003; 60(7):445-50. PubMed ID: 14750416
[TBL] [Abstract][Full Text] [Related]
45. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
[TBL] [Abstract][Full Text] [Related]
46. Soluble intercellular adhesion molecule-1 as a predictor of early adverse events in patients with chest pain compatible with myocardial ischemia.
Hillis GS; Terregino C; Taggart P; Killian A; Zhao N; Kaplan J; Dalsey WC; Mangione A
Ann Emerg Med; 2001 Sep; 38(3):223-8. PubMed ID: 11524640
[TBL] [Abstract][Full Text] [Related]
47. Soluble adhesion molecules in acute ischemic stroke.
Simundic AM; Basic V; Topic E; Demarin V; Vrkic N; Kunovic B; Stefanovic M; Begonja A
Clin Invest Med; 2004 Apr; 27(2):86-92. PubMed ID: 15202827
[TBL] [Abstract][Full Text] [Related]
48. The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.
Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Karkantaris C; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Pizzolo G; Pangalis GA
Haematologica; 2002 Jul; 87(7):701-8; discussion 708. PubMed ID: 12091120
[TBL] [Abstract][Full Text] [Related]
49. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.
Glowinska B; Urban M; Peczynska J; Florys B
Metabolism; 2005 Aug; 54(8):1020-6. PubMed ID: 16092051
[TBL] [Abstract][Full Text] [Related]
50. Association of mineral metabolism with an increase in cellular adhesion molecules: another link to cardiovascular risk in maintenance haemodialysis?
Arici M; Kahraman S; Gençtoy G; Altun B; Kalyoncu U; Oto A; Kirazli S; Erdem Y; Yasavul U; Turgan C
Nephrol Dial Transplant; 2006 Apr; 21(4):999-1005. PubMed ID: 16326734
[TBL] [Abstract][Full Text] [Related]
51. Impact of rHuEPO therapy initiation on soluble adhesion molecule levels in haemodialysis patients.
Kahraman S; Yilmaz R; Kirkpantur A; Genctoy G; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
Nephrology (Carlton); 2005 Jun; 10(3):264-9. PubMed ID: 15958039
[TBL] [Abstract][Full Text] [Related]
52. Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation.
Flori HR; Ware LB; Glidden D; Matthay MA
Pediatr Crit Care Med; 2003 Jul; 4(3):315-21. PubMed ID: 12831413
[TBL] [Abstract][Full Text] [Related]
53. Soluble intercellular adhesion molecule-1 (ICAM-1) in serum and urine: correlation with renal expression of ICAM-1 in patients with kidney disease.
Lhotta K; Schlögl A; Kronenberg F; Joannidis M; König P
Clin Nephrol; 1997 Aug; 48(2):85-91. PubMed ID: 9285144
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
55. Longitudinal course and clinical significance of TGF-beta1, sL- and sE-Selectins and sICAM-1 levels during severe acute stress in children.
Briassoulis G; Papassotiriou I; Mavrikiou M; Lazaropoulou C; Margeli A
Clin Biochem; 2007 Mar; 40(5-6):299-304. PubMed ID: 17291476
[TBL] [Abstract][Full Text] [Related]
56. [Changes and clinical significance of serum IL-6, sICAM-1 in patients with cerebral infarcts].
Liu ZJ; Yang QD; Liu YH; Huang XS; Zhang N
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):326-9. PubMed ID: 16136971
[TBL] [Abstract][Full Text] [Related]
57. [Serum soluble adhesion molecules--sICAM-1, sVCAM-1, sE-selectin--in patients with systemic rheumatoid arthritis].
Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
Pol Merkur Lekarski; 2004 Oct; 17(100):353-6. PubMed ID: 15690700
[TBL] [Abstract][Full Text] [Related]
58. Serum levels of circulating intercellular adhesion molecule-1 in patients with breast cancer.
Sheen-Chen SM; Eng HL; Sheen CW; Cheng YF; Chou FF; Chen WJ
Anticancer Res; 1997; 17(4A):2823-6. PubMed ID: 9252723
[TBL] [Abstract][Full Text] [Related]
59. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.
Goto N; Tsurumi H; Takemura M; Hara T; Sawada M; Kasahara S; Kanemura N; Yamada T; Shimizu M; Takahashi T; Tomita E; Seishima M; Takami T; Moriwaki H
Eur J Haematol; 2006 Sep; 77(3):217-25. PubMed ID: 16856931
[TBL] [Abstract][Full Text] [Related]
60. Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features.
Møller MB; Nielsen O; Pedersen NT
Am J Clin Pathol; 2001 Mar; 115(3):404-12. PubMed ID: 11242797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
